Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Immune alterations and overexpression of CTCF in endometrial carcinoma: insights from molecular subtyping

Fig. 3

Validation of expression of representative DEGs in clinical samples. qRT-PCR assay was performed to validate the expression of selected DEGs in EC samples and tumor-adjacent samples. Normal: n = 10; Cancer: n = 20. A MUC16 was up-regulated in EC. B ARID1A expression exhibited no significant difference. C PIK3R1 was up-regulated in EC. D CTCF was up-regulated in EC. E PIK3CA was up-regulated in EC. F There was no notable variation in the expression of KMT2D."ns" indicates non-significant, **p < 0.01, ***p < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us